Measurement of tumor size in early cervical cancer: an ever-evolving paradigm.


Journal

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626

Informations de publication

Date de publication:
08 2020
Historique:
received: 30 03 2020
revised: 25 05 2020
accepted: 02 06 2020
pubmed: 9 7 2020
medline: 10 9 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

The major tenets in accurately assessing tumor size in patients with early stage cervical cancer currently include physical examination, imaging studies, and pathologic evaluation. It is estimated that when comparing clinical stage based on physical examination and final pathology, the concordance diminishes as stage increases: 85.4%, 77.4%, 35.3%, and 20.5% for stage IB1, IB2, IIA, and IIB, respectively. Vaginal involvement and larger tumor diameter are considered the main causes of stage inaccuracy. When considering imaging studies, magnetic resonance imaging (MRI) provides the highest level of accuracy in the assessment of cervical tumor size. Its accuracy in determining tumor location within the cervix is approximately 91% and in predicting tumor size 93%. MRI imaging is also significantly more accurate in measuring tumor size, delineating cervical tumor boundaries, and local tumor extension when compared with computed tomography (CT) scan. When comparing with pelvic ultrasound, the accuracy of both imaging techniques (MRI and pelvic ultrasound) in the assessment of tumor size in small versus large tumors is comparable. Pertaining to pathology, the depth of invasion should be measured by convention from the nearest surface epithelium, which equates to tumor thickness. In the setting where tumor is found both in the conization and hysterectomy specimen, the horizontal extent should be measured by summing the maximum horizontal measurement in the different specimens and the depth of invasion measured as the maximum depth in either specimen. A new pattern-based classification for endocervical adenocarcinomas recommends the description of patterns of invasion for human papillomavirus (HPV)-related adenocarcinomas as this is associated with differing risks of lymph node involvement.

Identifiants

pubmed: 32636272
pii: ijgc-2020-001436
doi: 10.1136/ijgc-2020-001436
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1215-1223

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Gloria Salvo (G)

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA glorietasalvo@gmail.com.

Diego Odetto (D)

Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.

Marie Catherine Saez Perrotta (MC)

Department of Pathology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.

Florencia Noll (F)

Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.

Myriam Perrotta (M)

Department of Gynecologic Oncology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.

Rene Pareja (R)

Gynecologic oncology, Clinica ASTORGA, Medellin, Colombia.
Gynecologic oncology, Instituto Nacional de Cancerología, Bogota, Colombia.

Alejandra Wernicke (A)

Department of Pathology, Hospital Italiano de Buenos Aires, CABA, Buenos Aires, Argentina.

Pedro T Ramirez (PT)

Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH